According to our (Global Info Research) latest study, the global Long-term Artificial Heart Support market size was valued at US$ 1996 million in 2025 and is forecast to a readjusted size of US$ 3840 million by 2032 with a CAGR of 9.8% during review period.
In 2025, global Long-term Artificial Heart Support production reached approximately 19,000 units, with an average global market price of around US$100,000 per unit. In 2025, the global 's total production capacity of Long-term Artificial Heart Support reached 23,000 units. The industry average gross profit margin of this product reached 70%.Long-term assist devices (LADs) are implantable medical devices designed to replace or partially replace the pumping function of a damaged natural heart, providing long-term life support for patients with end-stage heart failure. They use a mechanical pump to pump blood from the heart and deliver it throughout the body. LADs are mainly categorized into total artificial hearts that replace the function of both ventricles and left ventricular assist devices that assist the function of a single ventricle. Unlike short-term transitional devices, the core design principle of LADs is extremely high durability, biocompatibility, and reliability to support patients in maintaining a high quality of life outside the hospital. Their goal is to serve as an "endpoint treatment" or a long-term "bridging therapy," significantly extending patient survival and improving exercise tolerance and quality of life.
The long-term assistive artificial heart (LTA) industry chain is highly integrated and has extremely high technological barriers. The upstream mainly includes the supply of core materials and components, such as biocompatible materials like titanium alloys and bioceramics; core drive and control components such as high-efficiency micromotors, magnetic levitation bearings, and precision sensors; and high-performance batteries and transcutaneous energy transfer systems. The midstream is the core of the industry chain, involving equipment design and development, precision manufacturing, animal and clinical trials, and stringent registration and approval processes. Representative companies include international giants such as Abbott and Medtronic. The downstream is the clinical application end, including large heart centers and cardiac surgery teams in transplant hospitals, responsible for patient screening, implantation surgery, long-term postoperative management, and anticoagulation therapy. The industry chain also relies heavily on continuous R&D investment, a strict regulatory system, and professional technical support and training services.
The long-term assistive artificial heart has a promising future, driven by both huge clinical demand and technological innovation. The global number of heart failure patients is large and continues to grow, while there is a severe shortage of heart donors, making long-term assistive devices an irreplaceable solution. Technological advancements are moving towards miniaturization, full implantability, intelligence, and high biocompatibility. For example, improved blood contact interface design can significantly reduce the risk of thrombosis and bleeding; wireless power transfer technology can eliminate the risk of infection associated with percutaneous leads; and artificial intelligence algorithms can achieve adaptive adjustment of pump speed. Indications are expanding from the traditional "transplant transition" to earlier "endpoint treatment" and "disease-modifying therapy." With technological maturity and cost control, market penetration is expected to increase, bringing hope to more patients.
This report is a detailed and comprehensive analysis for global Long-term Artificial Heart Support market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Long-term Artificial Heart Support market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Long-term Artificial Heart Support market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Long-term Artificial Heart Support market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Long-term Artificial Heart Support market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Long-term Artificial Heart Support
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Long-term Artificial Heart Support market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Berlin Heart, CARMAT, BiVACOR, SynCardia, Jarvik Heart, Aerospace Taixin Technology, Briohealth Tech, Shenzhen Core Medical Technology Co., Ltd., Evaheart, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Long-term Artificial Heart Support market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Left Ventricular Assist
Right Ventricular Assist
Biventricular Assist
Market segment by Assist Time
Temporary Support
Permanent Support
Market segment by Mode of Contact with Blood
Contact Type
Non-contact Type
Market segment by Application
Heart Failure
Cardiomyopathy
Others
Major players covered
Abbott
Berlin Heart
CARMAT
BiVACOR
SynCardia
Jarvik Heart
Aerospace Taixin Technology
Briohealth Tech
Shenzhen Core Medical Technology Co., Ltd.
Evaheart
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Long-term Artificial Heart Support product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Long-term Artificial Heart Support, with price, sales quantity, revenue, and global market share of Long-term Artificial Heart Support from 2021 to 2026.
Chapter 3, the Long-term Artificial Heart Support competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Long-term Artificial Heart Support breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Long-term Artificial Heart Support market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Long-term Artificial Heart Support.
Chapter 14 and 15, to describe Long-term Artificial Heart Support sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Long-term Artificial Heart Support. Industry analysis & Market Report on Long-term Artificial Heart Support is a syndicated market report, published as Global Long-term Artificial Heart Support Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Long-term Artificial Heart Support market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.